Since January 2019, the Vimex team has been participating in the European scientific project under the Horizon 2020 program entitled: „ ADvanced nanocomposite MAterI-als fOr in situ treatment and ultRAsound-mediated management of osteoarthritis”.

The project is carried out by an international consortium. Our company has been included in the group of remarkable universities and entrepreneurs:

  • SCUOLA SUPERIORE DI STUDI UNIVERSITARIE DI PERFEZIONAMENTO SANT'ANNA (Italy)
  • BAR ILAN UNIVERSITY (Israel)
  • ISTITUTO ORTOPEDICO RIZZOLI (Italy)
  • REGENTIS BIOMATERIALS LTD (Israel)
  • IMAGE GUIDED THERAPY SA (France)
  • PLASMACHEM PRODUKTIONS- UND HANDEL GMBH (Germany)
  • HITECH DEVELOPMENT WIRELESS SWEDENAB (Sweden)
ADMAIORA aims, in the long-term, at increasing the healthy and active lifespan of people affected by osteoarthritis. This results will be achieved by considerably slowing down or even stopping the degeneration process, acting during osteoarthritis at early stage. To make this challenging objective a reality, the partners will work together to merge into a unique workflow nanotechnologies, advanced materials, remotely physical stimulation, advanced manufacturing, wearable devices and cloud platforms.
The Vimex Endoscopy® team is developing and manufacturing in the project an innovative handheld 3D bioprinter, integrated in an arthroscopic tool, for in situ administration to cartilage, in a minimally invasive procedure, of a mixture of nano-composite hydrogel and cells.
If you want to learn more about the details of the project, please follow: (European Union’s Horizon 2020 Research and Innovation Programme - Grant Agreement No. 814413)
x